UK markets closed

MacroGenics, Inc. (MGNX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
16.23+0.82 (+5.32%)
At close: 04:00PM EDT
15.70 -0.53 (-3.27%)
After hours: 04:34PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 965.31M
Enterprise value 769.47M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)16.71
Price/book (mrq)6.33
Enterprise value/revenue 13.45
Enterprise value/EBITDA 381.49

Trading information

Stock price history

Beta (5Y monthly) 2.11
52-week change 3132.08%
S&P500 52-week change 323.06%
52-week high 321.88
52-week low 34.29
50-day moving average 316.91
200-day moving average 39.60

Share statistics

Avg vol (3-month) 31.58M
Avg vol (10-day) 3974.21k
Shares outstanding 562.56M
Implied shares outstanding 662.56M
Float 852.17M
% held by insiders 12.61%
% held by institutions 1100.54%
Shares short (28 Mar 2024) 46.45M
Short ratio (28 Mar 2024) 43.58
Short % of float (28 Mar 2024) 412.65%
Short % of shares outstanding (28 Mar 2024) 410.30%
Shares short (prior month 29 Feb 2024) 45.02M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -15.42%
Operating margin (ttm)-460.39%

Management effectiveness

Return on assets (ttm)-36.33%
Return on equity (ttm)-6.15%

Income statement

Revenue (ttm)58.75M
Revenue per share (ttm)0.95
Quarterly revenue growth (yoy)-85.30%
Gross profit (ttm)N/A
EBITDA -158.6M
Net income avi to common (ttm)-9.06M
Diluted EPS (ttm)-0.15
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)229.8M
Total cash per share (mrq)3.68
Total debt (mrq)33.97M
Total debt/equity (mrq)22.26%
Current ratio (mrq)4.48
Book value per share (mrq)2.46

Cash flow statement

Operating cash flow (ttm)-78.2M
Levered free cash flow (ttm)-25.04M